Načítá se...
Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
A 64‐year‐old woman, who had presented with a 30‐year history of refractory asthma, and been treated with anti‐allergic drug therapy, inhaled corticosteroids, a long‐acting beta‐agonist, and a long‐acting muscarinic antagonist. She had been characterized as an allergic, eosinophilic asthmatic. Altho...
Uloženo v:
| Vydáno v: | Respirol Case Rep |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249091/ https://ncbi.nlm.nih.gov/pubmed/30479771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.388 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|